Posts tagged CRH Medical
RBC upgrades CRH Medical to OP

RBC Capital Markets upgraded CRH Medical (TSX:CRH; NYSE MKT:CRHM) to “outperform” from “sector perform” but lowered its price target to $6 (Canadian) from $8.50. The stock closed at $4.07 on July 20.

Read More
RBC starts CRH Medical at outperform

RBC Capital Markets initiated coverage of CRH Medical (NYSE MKT:CRHM; TSX:CRH) with an “outperform” rating and price target of $6.50 (Canadian). The stock closed at $5.50 on Wednesday.

Analyst Doug Miehm writes that CRH has leveraged its long-standing GI physician relationships and expertise to acquire anesthesiology service businesses in the GI space.

Read More